Intraoperative dexmedetomidine and postoperative cerebral hyperperfusion syndrome in patients who underwent superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: A retrospective observational study

Dexmedetomidine, a selective α(2)-agonist, reduces cerebral blood flow and has neuroprotective effects against cerebral ischemia/reperfusion injury in experimental animals. We examined whether intraoperative dexmedetomidine would reduce the incidence of postoperative cerebral hyperperfusion syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Hyungseok, Ryu, Ho-Geol, Son, Je Do, Kim, Jeong-Soo, Ha, Eun Jin, Kim, Jeong-Eun, Park, Hee-Pyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207568/
https://www.ncbi.nlm.nih.gov/pubmed/28033272
http://dx.doi.org/10.1097/MD.0000000000005712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207568/
https://www.ncbi.nlm.nih.gov/pubmed/28033272
http://dx.doi.org/10.1097/MD.0000000000005712

Ejemplares similares